113. Muscular dystrophy Clinical trials / Disease details
Clinical trials : 646 / Drugs : 471 - (DrugBank : 105) / Drug target genes : 59 - Drug target pathways : 170
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT05558813 (ClinicalTrials.gov) | November 2022 | 15/4/2022 | Natural History of Duchenne Muscular Dystrophy Cardiomyopathy (DMD-CMP) | Prospective Cardiac Magnetic Resonance Imaging Study in Duchenne Muscular Dystrophy (DMD-CMP) | Duchenne Muscular Dystrophy | Diagnostic Test: Cardiac MRI;Biological: Blood assays | Assistance Publique - Hôpitaux de Paris | NULL | Not yet recruiting | 6 Years | N/A | Male | 150 | N/A | France |